top of page
Scleroderma Apex: Mapping the Path to Effective Therapy in Systemic Sclerosis
Fri, Feb 02
|Virtual Event - two half-days
Exclusively for pharmaceutical and biotech colleagues to discuss latest advancements and management of systemic sclerosis with global scientific experts.
Registration for Scleroderma Apex is closed. Contact us at Apex@FriendsWSF.org with questions.
See other events
Time & Location
Feb 02, 2024, 9:00 AM PST – Feb 03, 2024, 2:00 PM PST
Virtual Event - two half-days
About the event
Designed specifically for pharmaceutical and biotech colleagues, Scleroderma Apex provides a platform to share knowledge and innovations from global experts in the field of scleroderma. The purpose of the program includes the following:
- Updates and understanding of the pathogenesis of systemic sclerosis and related interstitial lung disease;
- Clinical trials and regulatory aspects, potential challenges in trial design, and ways to overcome them;
- Critical overview of lessons learned from recent scleroderma trials.
The schedule is set to Pacific Standard Time.
Schedule
15 minutesCo-Chairs' Opening Remarks - Dinesh Khanna, MD, MSc and Dan Furst, MD
45 minutesUpdate on Pathogenesis of Systemic Sclerosis: What Have We Learned? - John Varga, MD
18 more items available
Scroll down to see event schedule.
bottom of page